They’re eating their own dog food, the Foolish CAPs are set in their direction, and even stockGuru has a fairly close re-entry point today. But NABI’s sudden climb to a new level in November 2009 has me concerned. Still, it has potential, so setting a paranoid limit buy at 5.04Cheap, Lazy Reference links: Yahoo! Finance, Wall Street Survivor, Motley Fool CAPS, TheStreet, Google Finance, MSN Money
Nabi Biopharmaceuticals (NABI)
You must be logged in to post a comment.